Treatment of Non-Anemic Iron Deficiency in Pregnancy
Status:
Not yet recruiting
Trial end date:
2023-11-15
Target enrollment:
Participant gender:
Summary
The objective is to investigate the treatment of non-anemic iron deficiency (NAID) and the
impact on development of anemia later in pregnancy. Anemia in the third trimester has been
identified as a risk factor for maternal and fetal morbidity that might lead to mortality.
Due to the high incidence of NAID in pregnancy, there is an opportunity for early screening
and treatment to decrease progression to anemia. The primary aim of this study is to
establish if treatment of NAID will result in higher third trimester hemoglobin values and
decrease incidence of anemia at term.